Skip to main content
Premium Trial:

Request an Annual Quote

Mark Balsano, David Stowell

N-of-One has added Mark Balsano and David Stowell to its executive team.

Balsano joins the company in the role of vice president of sales. Previosly, he held the same position at Response Genetics. In his new role at N-of-One, he'll work with the company's commercial team to support growing demand from cancer centers and diagnostics companies.  

Stowell is N-of-One's new vice president of operations. Previously, he was senior vice president of client services at Optum. Before that, he was vice president of client managment and client operations at Picis. At N-of-One, he will be responsible for daily operations, product management, solution implementation, and client management and support.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.